Search - tctmd.com

Displaying 121 - 140 of 154

Sort: Relevancy | Date

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Conference News TCT 2014

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

September 14, 2014

News Conference News TCT 2014

Lively Debate on Use of TAVR for Lower-Risk Patients

September 14, 2014

Presentation TCT 2014

TAVR Is Preferred for All but the Lowest-Risk Patients!

Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Alec S. Vahanian

September 13, 2014

Presentation TCT 2014

CON: A Call for Reason and Restraint!

Presenter: Michael J. Mack

September 13, 2014

Presentation TCT 2014

PRO: It has Already Happened and Is Justified!

Presenter: Nicolo Piazza

September 13, 2014

News Conference News TCT 2014

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

Todd Neale

September 13, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Conference News TCT 2013

TAVR a Viable Option for Intermediate-Risk Patients

November 05, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

Presentation TCT 2013

Which Aortic Stenosis Patients Are Too Low-Risk for TAVR?

Presenter: Raj Makkar

October 27, 2013

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 31, 2012

News Conference News TCT 2012

Two Trials Examine Device-Based PFO Closure

October 25, 2012

News Conference News TCT 2012

TRILOGY ACS Substudy: Angiography Prior to Prasugrel Therapy Reduces CV Events

October 25, 2012

News Conference News TCT 2012

ADAPT-DES: Poor Clopidogrel Response Not Predictive of 1-Year Mortality

October 25, 2012

Advertisement

TCT Course Director Outlines Current TAVR Controversies

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

Lively Debate on Use of TAVR for Lower-Risk Patients

TAVR Is Preferred for All but the Lowest-Risk Patients!

CON: A Call for Reason and Restraint!

PRO: It has Already Happened and Is Justified!

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

TAVR a Viable Option for Intermediate-Risk Patients

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

OPTIMIZE: 3-Month DAPT Safe with ZES

Two Trials to Assess TAVR in Moderate-Risk Patients

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Which Aortic Stenosis Patients Are Too Low-Risk for TAVR?

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

Two Trials Examine Device-Based PFO Closure

TRILOGY ACS Substudy: Angiography Prior to Prasugrel Therapy Reduces CV Events

ADAPT-DES: Poor Clopidogrel Response Not Predictive of 1-Year Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content